SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-018014
Filing Date
2019-11-19
Accepted
2019-11-19 17:04:27
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 634429
2 ex31-1.htm EX-31.1 18583
3 ex31-2.htm EX-31.2 18428
4 ex32-1.htm EX-32.1 8177
5 ex32-2.htm EX-32.2 8239
  Complete submission text file 0001493152-19-018014.txt   4798843

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rspi-20190930.xml EX-101.INS 952801
7 XBRL SCHEMA FILE rspi-20190930.xsd EX-101.SCH 75022
8 XBRL CALCULATION FILE rspi-20190930_cal.xml EX-101.CAL 44498
9 XBRL DEFINITION FILE rspi-20190930_def.xml EX-101.DEF 228080
10 XBRL LABEL FILE rspi-20190930_lab.xml EX-101.LAB 447766
11 XBRL PRESENTATION FILE rspi-20190930_pre.xml EX-101.PRE 304541
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 191231996
SIC: 2834 Pharmaceutical Preparations